nissha2019/03/22 · l.g5 /e< @= $ ' " bd l i 9.?- jc3 !%+( l ' l ' l '...
TRANSCRIPT
NISSHA CONFIDENTIAL PROPRIETARY 2
"6'���&$)�#!���
��- ����� ����� ����
��- ��- �����
*,�+
��(����-��%
IT
NISSHA CONFIDENTIAL PROPRIETARY 3
l7=!;��!1 ����?�� -�&�"B>���M&A����
2019����#�/+3�2����"B
7=!;
�!1 ����? � -
�#�/+3 M&A,2315*��2018-2020 3���+�
$�
6��280*�
��)�
$�
�@�'<
lIT�49%�:5%�A(�8.
IT
A(
0C
NISSHA CONFIDENTIAL PROPRIETARY 4
x|
V}w
`~[^MLgm
lRraela[OT�EA�XD�oc
NISSHA���_d
&�.�" �11(/�2018712@59 iSEZ
.!��2 �%3��=;=;EZ37�6p{�N<Ky�vQ
)�2-�Roll-to-Roll
�� �4�� 1,$��04� '��4#4��
®
gmJk
Nj�
l?>*14"la[1�4��+�oq
RSS Design, LLC201876@b\
�P]�598B��ae�iS���� ��
sCYGVUGUlgmJkz:ft�26B2X10027V03001
gmJkz:ft�26B2X10027V01001�26B2X10027V0100226B2X10027V01003�26B2X10027V01005
FIGnuHUl
�hW��.�����
�P]�598B��ae�iS���� ��
NISSHA CONFIDENTIAL PROPRIETARY 5
DH
%4IC
1K- .GF<
lJF�5B@��F</A�&$("
NISSHA���06
�� ��Roll-to-Roll
����!�L ������!L ���!�!�L
9?(=
*<L
Drug Delivery System�@+2:�����DDS�#,'
.GF<�;
E@8>
)@37
3F37
9@-��� ���!
NISSHA CONFIDENTIAL PROPRIETARY 6
l2,H:B: =;A3�7�� &! "�����0Cl?9�5/�ED.���
�����%������0C�����-�H:B�+*1)�@(
-16�����0C
FGNISSHA�� 8<
����'�I $!���#' ���'�'�4>I
NISSHA CONFIDENTIAL PROPRIETARY 7
G:B2�����"&!����-C;,l3(64!����������) ��EU��l.4/�><8E�91�5+��*�!����-C�@A
).4!����-C
DFNISSHA���7=
����'�H %# ��$' !��'�'�0?HH
NISSHA CONFIDENTIAL PROPRIETARY 8
/���&'��NISSHA*)1(,09
l2Gl1;3���l2G7K���
l.Gl7K �%#�4A=l.G5�/E<�@=$�'�"BD
lI<8F9l6H������
Autonomous�,0:>�
9.?-JC3 ����!%+(
��������
l�'�� ��l����'��l ����'��